OOIR: Observatory of International Research

Papers

(The TQCC of Hematology-Oncology Clinics of North America is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver	65
Conflict and Access to Health Care	49
Managing First-Line Metastatic Renal Cell Carcinoma	45
Forthcoming Issues	44
Copyright	44
Remote Telemonitoring and Telehealth in Surgical Oncology	43
Insights into Renal Cell Carcinoma with Novel Imaging Approaches	42
Contents	39
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia	39
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis	34
Contemporary Management of Dermatofibrosarcoma Protuberans	32
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia	26
Treatment of High-Risk Gestational Trophoblastic Neoplasia	23
Copyright	22
Hematology/Oncology Clinics of North America	21
Contributors	20
Copyright	18
Contributors	18
Contents	18
From Molecular Match to Surgical Decision: Precision Oncology Through a Surgical Lens	17
Advances in Gastric Cancer Surgical Management	17
Future Directions for Gestational Trophoblastic Disease	17
The Landscape of Personalized Medicine in Gynecologic Cancer	17
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	16
Contents	15

Benefits and Harms of Interception and Early Detection of Cancer	15
Advances in Surgical Techniques for Lung Cancer	15
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	15
Advances in Immunotherapy in Esophagogastric Cancer	15
Disparities in Breast Cancer Outcomes and How to Resolve Them	15
Contents	15
Clinical Characteristics and Treatment of Histiocytic Disorders in Children	14
Genomic Alterations in Langerhans Cell Histiocytosis	14
Histiocytic Disorders in Pediatric and Adult Patients	14
Foreword	14
Advances in Systemic Therapy in Pancreatic Cancer	14
The Need for Translational Epidemiology in Beta Thalassemia Syndromes	13
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas	13
Emerging Therapies in β-Thalassemia	13
Transhepatic Biliary Intervention for Malignant Biliary Obstruction	12
Forthcoming Issues	12
Emerging Therapeutic Targets for Platinum-Resistant Ovarian Cancer	12
Clinical Vignettes Part I	12
Advances in Neuroblastoma and Wilms Tumor	12
Liposarcoma	12
Forthcoming Issues	12
Hereditary Renal Cell Carcinoma Syndromes	11
The Evolving Role of Surgery in Multimodal Cancer Care	11
Evaluation and Management of Bing–Neel Syndrome	11
Skin Cancer Precursors	11
Malignancies of the Upper Gastrointestinal Tract	11
Genes as Medicine	11
Patient-Reported Outcomes in Radiation Oncology	10
Bispecific Antibodies in the Treatment of Multiple Myeloma	10
Copyright	10
Contents	10
New Developments in Myeloma	10
Gestational Trophoblastic Neoplasia	10
CAR T Cells: Past Successes, Current Limitations, and Future Opportunities	10
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy	9
Management of In-Transit Metastatic Melanoma	9
High-Risk Non-Melanoma Skin Cancers	9
Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime?	9
Contributors	9
Advances in the Surgical Management of Esophageal Cancer	9
Forthcoming Issues	9
Copyright	8
Local Control in Soft Tissue Sarcomas	8
Contents	8
Evolution of Gene Therapy, Historical Perspective	8
Heavy Ion Particle Therapy in Modern Day Radiation Oncology	8
Forthcoming Issues	8
Palliative Therapy for Liver and Biliary Neoplasms	8
Copyright	7
Advances in Pediatric Hodgkin Lymphoma with an Eye on Disparities and Vulnerable Populations	7

Breast Cancer and Lifestyle Factors	7
Breast Cancer in India	7
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer	7
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma	7
Clinical Complications and Their Management	7
Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers	7
Contents	7
Radiation-Induced Tissue Regeneration	7
Melanoma Brain Metastasis	7
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases	7
Targeted Therapy Innovations for Melanoma	6
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?	6
Education and Training Models for Remote Learning	6
Early-Stage Hodgkin Lymphoma	6
Copyright	6
Advances in Cervical Cancer	6
Impact of Clonal Heterogeneity in Multiple Myeloma	6
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors	6
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies	6
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia	6
Ductal Carcinoma In Situ	6
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma	6
Early Detection of Precursor Diseases of Multiple Myeloma	6
FLASH Radiotherapy	6
Hemophilia A/B	6
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma	6
Immune-Pathogenesis of Myeloma	6
Contributors	6
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy	6
Forthcoming Issues	5
Renal Cell Cancer	5
Management of Waldenström Macroglobulinemia in Limited-Resource Settings	5
Pathogenic Mechanisms in Thalassemia II	5
Surgery for Recurrent Ovarian Cancer	5
Merkel Cell Carcinoma	5
Contributors	5
Approach to High-Risk Multiple Myeloma	5
When Is It Important to Sequence Sarcomas and Other Mesenchymal Neoplasms? A Practical Guide to Molecular Testing	5
Contents	5
Transarterial Therapy for Liver Tumors	5
Contents	5
Remembering the Contributions of Professor David J. Weatherall	5
Pathogenic Mechanisms in Thalassemia I	5
Sarcomas	5
Contents	5
Genetics and Genomics of Gestational Trophoblastic Disease	5